ArkeaBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $15M

  • Investors
  • 6

ArkeaBio General Information

Description

Developer of an agricultural bioscience technology designed to reduce methane emissions from cattle through vaccination. The company's technology produces a vaccine that targets methane-producing microbes in the digestive systems of livestock, enabling farmers and food producers to lower the environmental footprint of agriculture and mitigate global warming.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 Rutherford Avenue
  • Suite 320
  • Charlestown, MA 02129
  • United States
+1 (833)
Primary Industry
Other Agriculture
Other Industries
Animal Husbandry
Biotechnology
Corporate Office
  • 500 Rutherford Avenue
  • Suite 320
  • Charlestown, MA 02129
  • United States
+1 (833)

ArkeaBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ArkeaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A2) 30-Sep-2026 $15M Completed Generating Revenue
3. Early Stage VC (Series A1) 22-Dec-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 03-May-2024 $26.5M $38.5M Completed Generating Revenue
1. Seed Round 01-Dec-2022 $12M $12M Completed Generating Revenue
To view ArkeaBio’s complete valuation and funding history, request access »

ArkeaBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Series A
Seed 1,428,960 $0.000010 8% $7 $7 1x $7 8.61%
Pre-Seed 2,000,000 $0.000010 8% $1 $1 1x $1 12.05%
To view ArkeaBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ArkeaBio Patents

ArkeaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026213426-A2 Methanogens for cell-based vaccines Pending 02-Apr-2025
US-20250231566-A1 Sun glare avoidance system (sas) in semi or fully autonomous vehicles Pending 12-Jan-2024
AU-2025207062-A1 Nucleic acid vaccines targeting methanogens Pending 10-Jan-2024
WO-2025151711-A1 Nucleic acid vaccines targeting methanogens Inactive 10-Jan-2024
AU-2025206768-A1 Protein and peptide vaccines targeting methanogens Pending 10-Jan-2024 A23K20/147
To view ArkeaBio’s complete patent history, request access »

ArkeaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ArkeaBio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AgriZeroNZ Impact Investing Minority
NYA Ventures Venture Capital Minority
Overview Capital Venture Capital Minority
Rabo Investments Venture Capital Minority
The Grantham Foundation Limited Partner Minority
You’re viewing 5 of 6 investors. Get the full list »

ArkeaBio FAQs

  • When was ArkeaBio founded?

    ArkeaBio was founded in 2021.

  • Where is ArkeaBio headquartered?

    ArkeaBio is headquartered in Charlestown, MA.

  • What is the size of ArkeaBio?

    ArkeaBio has 31 total employees.

  • What industry is ArkeaBio in?

    ArkeaBio’s primary industry is Other Agriculture.

  • Is ArkeaBio a private or public company?

    ArkeaBio is a Private company.

  • What is the current valuation of ArkeaBio?

    The current valuation of ArkeaBio is .

  • What is ArkeaBio’s current revenue?

    The current revenue for ArkeaBio is .

  • How much funding has ArkeaBio raised over time?

    ArkeaBio has raised $60.5M.

  • Who are ArkeaBio’s investors?

    AgriZeroNZ, NYA Ventures, Overview Capital, Rabo Investments, and The Grantham Foundation are 5 of 6 investors who have invested in ArkeaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process